lunes, 27 de noviembre de 2023

Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial

https://www.siicsalud.com/des/oatituloses.php/GAS

No hay comentarios:

Publicar un comentario